Cinolazepam

Cinolazepam

Cinolazepam
Systematic (IUPAC) name
(RS)-3-[9-Chloro-6-(2-fluorophenyl)-4-hydroxy-3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-2-yl]propanenitrile
Clinical data
AHFS/Drugs.com
Pregnancy cat.
  • ?
Legal status
Routes Oral
Pharmacokinetic data
Bioavailability 90-100%
Metabolism Hepatic
Half-life 9 h[1]
Excretion Renal
Identifiers
CAS number  YesY
ATC code N05
PubChem
DrugBank
ChemSpider  YesY
UNII  YesY
KEGG  YesY
ChEBI  YesY
ChEMBL  N
Chemical data
Formula C18H13ClFN3O2 
Mol. mass 357.8
 N   

Cinolazepam[2] (marketed under the brand name Gerodorm)[3] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as an hypnotic.

Cinolazepam is not approved for sale in the United States or Canada.

See also

References

  1. ^ Saletu, B.; G. Kindshofer; P. Anderer; J. Grunberger (1987). "Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.". International Journal of Clinical Pharmacology Research 7 (5): 407–18.  
  2. ^ US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  3. ^ Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006. 

External links

  • Inchem.org - Cinolazepam